Multi-Analyte Neuro Profiling: Deconvoluting Axonal, Astroglial & Somatic Injury

Neurodegenerative diseases and traumatic brain injuries involve complex, interdependent multicellular cascades. Relying on a single fluid biomarker often fails to capture the true underlying multicellular pathology, as neuroaxonal structural loss, glial inflammatory activation, acute neuronal cytolysis, and amyloid aggregation occur along disparate biological timelines. Quanterix Simoa Multiplex Neurology Panels resolve these dynamics by measuring orthogonal biomarker pathways simultaneously from as little as 15 μL of blood plasma, serum, or CSF.

By deploying multi-color fluorescently encoded paramagnetic beads within isolated 50-femtoliter microwells, Simoa digital immunoassay technology quantifies sub-picogram concentrations of four key analytes in parallel without cross-reactivity or mutual interference. This multiplexing capability enables comprehensive mapping of the cellular hierarchy in preclinical models:

Cellular Origins & Kinetic Profiles of Core Neurology Analytes

  • Neurofilament Light (NfL): Structural cylindrical intermediate filament localized in large, myelinated subcortical and spinal axons. Reflects ongoing cumulative neuroaxonal injury with an extended circulation half-life (~3 weeks).
  • Glial Fibrillary Acidic Protein (GFAP): Cytoskeletal intermediate filament specific to astrocytes. Elevated rapidly in response to reactive astrogliosis, blood-brain barrier (BBB) breakdown, and intracerebral microvascular injury.
  • Ubiquitin C-Terminal Hydrolase L1 (UCH-L1): Abundant neuron-specific cytoplasmic deubiquitinating enzyme (~1–2 % of total brain soluble protein). Acts as an acute marker of immediate somatodendritic plasma membrane rupture with a short half-life (<12–24 hours).
  • Total Tau / BD-Tau: Microtubule-associated protein enriched in thin, non-myelinated cortical axons. Captures cortical axonal damage and acute ischemic/toxic neuroaxonal shedding.
  • Amyloid-Beta 42/40 Ratio (Aβ42/Aβ40): Essential marker of cerebral amyloid deposition; soluble Aβ42 depletion into insoluble parenchymal plaques yields a characteristic decrease in peripheral blood ratios.